Empowering Treatment with Confidence

In 2010, our founder Dr. David Farrell and his team discovered Gamma Prime Fibrinogen (GPF), a naturally occurring blood protein could potentially assess chronic inflammation and predict death by heart attack, and stroke (ARIC study). Since then, there has been a lot more research using GPF and recent studies have also shown efficacy in infectious/inflammatory diseases such as COVID-19. GPF could help clinicians potentially predict severity of the disease and empower doctors to make better treatment decisions for their patients.